These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8379641)

  • 1. Breast size and prognosis in early breast cancer.
    Duffett RH
    Ann R Coll Surg Engl; 1993 Jul; 75(4):300-1. PubMed ID: 8379641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of spread of the neoplastic process on prognosis in breast cancer].
    Ostrovtsev LD
    Khirurgiia (Mosk); 1983 Nov; (11):40-3. PubMed ID: 6664007
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of the "communication systems" in individual prognosis of breast cancer].
    Golubev OA
    Arkh Patol; 2004; 66(1):22-8. PubMed ID: 15055105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer in women aged 35 and under: prognosis and survival.
    Jmor S; Al-Sayer H; Heys SD; Payne S; Miller I; Ah-See A; Hutcheon A; Eremin O
    J R Coll Surg Edinb; 2002 Oct; 47(5):693-9. PubMed ID: 12463710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness and monitoring of breast cancer screening programs].
    Paci E; Day NE
    Epidemiol Prev; 1995 Dec; 19(65):310-7. PubMed ID: 8852080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast size as risk factor for tumor size at diagnosis.
    Hasenburg A; Grothey A; Jaspers V; Gitsch G; Spätling L
    Anticancer Res; 2000; 20(3B):2041-4. PubMed ID: 10928148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor burden of locally recurrent breast cancer is a neglected prognostic factor.
    Evans RA
    Am J Surg; 1996 Apr; 171(4):445-8. PubMed ID: 8604842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General rules for clinical and pathological recording of breast cancer 2005.
    Sakamoto G; Inaji H; Akiyama F; Haga S; Hiraoka M; Inai K; Iwase T; Kobayashi S; Sakamoto G; Sano M; Sato T; Sonoo H; Tsuchiya S; Watanabe T;
    Breast Cancer; 2005; 12 Suppl():S1-27. PubMed ID: 16410755
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of fine-needle aspiration on long-term survival rate and axillary lymph node micrometastasis in patients with early breast cancer.
    Kinoshita S; Uchida K; Kyoda S; Shioya H; Takeyama H; Morikawa T
    Breast J; 2007; 13(2):216-7. PubMed ID: 17319873
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
    Hanrahan EO; Valero V; Gonzalez-Angulo AM; Hortobagyi GN
    J Clin Oncol; 2006 May; 24(13):2113-22. PubMed ID: 16648513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410.
    Elston CW; Ellis IO
    Histopathology; 2002 Sep; 41(3A):151-2, discussion 152-3. PubMed ID: 12405945
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of breast cancer subtype classification to predict local and distant recurrence. A review].
    Belkacémi Y; Penault-Llorca F; Gligorov J; Azria D
    Cancer Radiother; 2008 Nov; 12(6-7):577-83. PubMed ID: 18824383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of nuclear morphology in breast cancer prognosis.
    Wolberg WH; Street WN; Mangasarian OL
    Clin Cancer Res; 1999 Nov; 5(11):3542-8. PubMed ID: 10589770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast cancer].
    Maass H
    Gynakologe; 1994 Feb; 27(1):1-2. PubMed ID: 8168731
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
    Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
    Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diseases of the female breast: clinical pathology].
    Torhorst J
    Ther Umsch; 1993 May; 50(5):307-13. PubMed ID: 8397447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.